New Cold-Dose Model Could Make Cryoablation More Precise
A new cumulative cold-dose model could help clinicians plan cryoablation by combining lethal temperature, exposure time, tissue sensitivity and repeated ...
A new cumulative cold-dose model could help clinicians plan cryoablation by combining lethal temperature, exposure time, tissue sensitivity and repeated ...
In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine